The targeted radiotherapies for cancer market is experiencing significant growth, driven by advancements in technology and ...
Johnson & Johnson is paying $3.05 billion to acquire Halda Therapeutics, obtaining a novel cell death platform while ...
The Race for the Global Radiotherapy Cancer Market; Actinium Pharmaceuticals’ (ATNM) Big Bet To view an enhanced version of ...
AdvanCell Pty Ltd ("AdvanCell"), a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the appointment of Philina Lee, PhD as Chief ...
The Independent on MSN
Grey’s Anatomy star reveals prostate cancer diagnosis
Grey’s Anatomy star reveals prostate cancer diagnosis – days after his character was given the same news - James Pickens Jr.
Daytime Confidential on MSN
Grey's Anatomy's James Pickens Jr. Reveals Prostate Cancer Diagnosis
Grey's Anatomy star James Pickens Jr. (Richard Webber) has announced he has prostate cancer. In an interview with Black ...
The identification of 20 causal plasma proteins for prostate cancer represents a critical step toward addressing the need for improved diagnostic specificity and reveals promising new targets for ...
Guselkumab (Tremfya; Johnson & Johnson) continued to reduce signs and symptoms of active psoriatic arthritis (PsA) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback